Biotech Blog Archives: September 2004
·
previous page
8 September 2004
The Trials of ImClone
The Trials of ImClone
“A founder in handcuffs, financials in disarray, and a vital product in doubt-for CEO Daniel Lynch, it was the turnaround from hell.”
continue reading... » 0 Comments
1 September 2004
Drug Patent Expirations in September 2004
Drug Patent Expirations in September 2004
continue reading... » 0 Comments
1 September 2004
The Time Is Right for These Seven Biotechs
The Time Is Right for These Seven Biotechs
“In most years, biotechs decline in the spring as investors anticipate a summer hiatus in the conferences where new clinical results are announced. They rally in the fall as the conference schedule and the volume of news increases … Buy when the playing field is biased in my [...]
